Campylobacter jejuni is the major cause of gastroenteritis in humans worldwide. It is a self-limiting disease with the symptoms varying from watery diarrhoea with no inflammation to mucous containing
BackgroundThe development of Guillain-Barré syndrome (GBS) during bortezomib treatment for multiple myeloma (MM) is rare. Clinical vigilance regarding this serious adverse event is imperative for time
The underlying change of gene network expression of Guillain-Barre syndrome (GBS) remains elusive. We sought to identify GBS-associated gene networks and signalling pathways by analyzing the transcrip
